In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
T R
TR
Ikerd
S L
SL
Koletar
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D017963:Azithromycin; D002939:Ciprofloxacin / Q000494:pharmacology*; D017291:Clarithromycin / Q000494:pharmacology*; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D024841:Fluoroquinolones; D016829:Giardia lamblia / Q000187:drug effects*; D008795:Metronidazole / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D015363:Quinolones / Q000494:pharmacology*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D008795:Metronidazole; C054745:temafloxacin; D002939:Ciprofloxacin; D004917:Erythromycin; D017963:Azithromycin; D017291:Clarithromycin